SERABELISIB
UNII 43J9Q56T3W

Substance Identification & Data

This profile provides standardized clinical and technical data for Serabelisib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 43J9Q56T3W.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1268454-23-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

43J9Q56T3W

CAS Registry Number

1268454-23-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SERABELISIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C19H17N5O3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

BLGWHBSBBJNKJO-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C98844

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

70798655

Unique identification number in the NCBI database of chemical substances.

INN ID

10369

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c12ccc(cn1c(cn2)C(=O)N3CCOCC3)-c4cc5c(cc4)oc(n5)N

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Serabelisib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.